Lowenstein partner James O’Grady spoke on the panel “Capital Markets Panel: Navigating Going Public in 2025” at Chardan’s 8th Annual Genetic Medicines Conference. The panel was moderated by David Lederman, Managing Director of Capital Markets at Chardan. O’Grady was joined on the panel by Jonas Grossman, Managing Partner and President of Chardan, and Raymond Camahort, Ph.D., Partner at Novo Holdings Venture Investments.
Moderator:
- David Lederman, Managing Director, Capital Markets of Chardan
Speakers:
- James O’Grady, Partner, Lowenstein Sandler LLP
- Jonas Grossman, Managing Partner, President, Chardan
- Raymond Camahort, Partner, Novo Holdings
Time: 10:30 a.m. ET
Location: New York, NY
